Innovative Imaging Technology Clarix Imaging offers the only commercially available CT-based specimen imaging system designed specifically for intraoperative breast cancer margin visualization, providing precise tumor delineation that can significantly improve surgical outcomes and reduce re-operation rates.

Growing Funding Support With a recent $10 million investment from Kineo Finance AG, Clarix Imaging demonstrates strong investor confidence and financial backing, creating opportunities to expand sales efforts and scale their advanced imaging solutions in the surgical oncology market.

Targeted Market Segment Focusing on the niche of intraoperative breast cancer surgeries, Clarix Imaging's product appeals directly to surgical centers and hospitals aiming to enhance precision and personalization in cancer treatment, making it an attractive solution for oncology departments looking for cutting-edge technology.

Tech-Driven Differentiation Utilizing advanced AI and volumetric imaging software, Clarix Imaging’s VSI-360™ system offers superior image clarity and real-time visualization, providing a competitive edge over traditional specimen imaging methods and opening doors for strategic partnerships with leading medical institutions.

Potential Expansion Opportunities Given its innovative technology and backed funding, Clarix Imaging can expand sales efforts into related surgical fields such as other types of oncologic resections or broader intraoperative imaging applications, broadening their market reach and increasing revenue streams.